Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Main Objective: To evaluate the percentage of patients with curatively unresectable MPNST who have achieved clinical response; complete response (CR), partial response (PR), or stable disease (SD) at 18 weeks as assessed by the Investigator, by using RECIST, v1.1.
Critère d'inclusion
- Malignant peripheral nerve sheath tumor (MPNST), not eligible for curative surgery